This is the standard starting dose during the first four weeks of escalation
Obesity-induced and weight-loss-induced physiological factors affecting weight regain
Originally developed to treat type 2 diabetes, Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) became a cultural phenomenon after the FDA first approved them for chronic weight management in 2021
If you have a type 2 diabetes diagnosis and solid insurance coverage, your plan will likely cover at least one branded GLP-1 medication, such as Ozempic, Victoza, or Rybelsus
Our medical provider will carefully assess your health history, lifestyle, and goals during your initial consultation, and recommend medication based on your unique needs
Lot numbers and pharmacy contact information should also appear on the label